High Prevalence of Mycobacterium Tuberculosis Infection and Disease in Children and Adolescents with Type 1 Diabetes Mellitus
Overview
Authors
Affiliations
Setting: Western Cape Province, South Africa.
Objectives: To describe the prevalence of tuberculosis (TB) infection and disease in children with type 1 diabetes and to investigate the association between glycaemic control and prevalence of TB infection and disease.
Design: Cross-sectional hospital-based study conducted at two public referral hospitals. All children and adolescents (aged <21 years) with type 1 diabetes underwent a Mantoux tuberculin skin test (>or=10 mm classified as Mycobacterium tuberculosis infection), measurement of glycosylated haemoglobin and a chest radiograph. Patients with symptoms suggestive of TB were investigated using mycobacterial culture. Radiologically and/or bacteriologically confirmed disease was classified as TB disease.
Results: Of 291 eligible patients, 258 (88.7%) were included (58% female). The prevalence of M. tuberculosis infection was 29.8% (95%CI 24.2-35.4); nine patients were diagnosed with prevalent TB disease (point prevalence disease 3488 per 100,000 population). Poor glycaemic control (hazard ratio 1.39, 95%CI 1.18-1.63 per unit increase in glycated haemoglobin [HbA1c]) and contact with a TB source case (P = 0.0011) was associated with prevalent TB disease.
Conclusions: There is a high prevalence of TB disease in diabetic children and adolescents in this setting. Routine TB screening of children with type 1 diabetes may be indicated in settings highly endemic for TB. Preventive treatment should be considered for diabetic children with proof of TB exposure and/or infection.
Kassie G, Adella G, Woldegeorgis B, Alemu A, Gebrekidan A, Haile K Heliyon. 2024; 10(21):e40140.
PMID: 39568839 PMC: 11577225. DOI: 10.1016/j.heliyon.2024.e40140.
Ye Z, Li L, Yang L, Zhuang L, Aspatwar A, Wang L Exploration (Beijing). 2024; 4(5):20230138.
PMID: 39439490 PMC: 11491313. DOI: 10.1002/EXP.20230138.
Jiang Y, Zhang W, Wei M, Yin D, Tang Y, Jia W Diabetol Metab Syndr. 2024; 16(1):60.
PMID: 38443967 PMC: 10913601. DOI: 10.1186/s13098-024-01296-x.
Majaliwa E, Muze K, Godfrey E, Byashalira K, Mmbaga B, Ramaiya K BMC Infect Dis. 2023; 23(1):740.
PMID: 37904143 PMC: 10614349. DOI: 10.1186/s12879-023-08753-4.
Sariol A, Vickers M, Christensen S, Weiskopf D, Sette A, Norris A J Infect Dis. 2023; 229(4):1059-1067.
PMID: 37624979 PMC: 11011175. DOI: 10.1093/infdis/jiad366.